To date, the role of serum MCP-1 as renal marker remains to be defined, as shown by the review by Liu et al. in which only few studies evaluated plasma or serum MCP-1 in human kidney diseases as a marker of risk of acute kidney injury or progression of kidney disease [80]. This evidence concerns the gene CCL2 and kidney disorder.